Centene EBITDA 2011-2025 | CNC
Centene annual and quarterly EBITDA history from 2011 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Centene EBITDA for the quarter ending September 30, 2025 was $-6.637B, a 778.63% decline year-over-year.
- Centene EBITDA for the twelve months ending September 30, 2025 was $-4.443B, a 209.76% decline year-over-year.
- Centene 2024 annual EBITDA was $4.416B, a 4.57% increase from 2023.
- Centene 2023 annual EBITDA was $4.223B, a 53.68% increase from 2022.
- Centene 2022 annual EBITDA was $2.748B, a 11.89% decline from 2021.
|
Centene Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $4,416 |
| 2023 | $4,223 |
| 2022 | $2,748 |
| 2021 | $3,119 |
| 2020 | $4,341 |
| 2019 | $2,424 |
| 2018 | $1,953 |
| 2017 | $1,560 |
| 2016 | $1,541 |
| 2015 | $854 |
| 2014 | $553 |
| 2013 | $344 |
| 2012 | $174 |
| 2011 | $262 |
| 2010 | $209 |
|
Centene Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-09-30 | $-6,637 |
| 2025-06-30 | $-143 |
| 2025-03-31 | $1,848 |
| 2024-12-31 | $489 |
| 2024-09-30 | $978 |
| 2024-06-30 | $1,535 |
| 2024-03-31 | $1,414 |
| 2023-12-31 | $121 |
| 2023-09-30 | $1,063 |
| 2023-06-30 | $1,496 |
| 2023-03-31 | $1,543 |
| 2022-12-31 | $69 |
| 2022-09-30 | $837 |
| 2022-06-30 | $199 |
| 2022-03-31 | $1,643 |
| 2021-12-31 | $840 |
| 2021-09-30 | $926 |
| 2021-06-30 | $-62 |
| 2021-03-31 | $1,415 |
| 2020-12-31 | $358 |
| 2020-09-30 | $1,159 |
| 2020-06-30 | $2,348 |
| 2020-03-31 | $476 |
| 2019-12-31 | $445 |
| 2019-09-30 | $338 |
| 2019-06-30 | $801 |
| 2019-03-31 | $840 |
| 2018-12-31 | $529 |
| 2018-09-30 | $180 |
| 2018-06-30 | $600 |
| 2018-03-31 | $644 |
| 2017-12-31 | $278 |
| 2017-09-30 | $431 |
| 2017-06-30 | $525 |
| 2017-03-31 | $326 |
| 2016-12-31 | $613 |
| 2016-09-30 | $420 |
| 2016-06-30 | $453 |
| 2016-03-31 | $55 |
| 2015-12-31 | $259 |
| 2015-09-30 | $240 |
| 2015-06-30 | $199 |
| 2015-03-31 | $156 |
| 2014-12-31 | $217 |
| 2014-09-30 | $131 |
| 2014-06-30 | $115 |
| 2014-03-31 | $90 |
| 2013-12-31 | $101 |
| 2013-09-30 | $101 |
| 2013-06-30 | $86 |
| 2013-03-31 | $55 |
| 2012-12-31 | $164 |
| 2012-09-30 | $-11 |
| 2012-06-30 | $-30 |
| 2012-03-31 | $51 |
| 2011-12-31 | $76 |
| 2011-09-30 | $63 |
| 2011-06-30 | $70 |
| 2011-03-31 | $53 |
| 2010-12-31 | $59 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Health Maintenance Organizations | $16.834B | $163.071B |
| Centene Corporation is a well-diversified, multi-national healthcare company that primarily provides a set of services to government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services. Through a diversified product portfolio and expanding geographic reach, Centene continues to deliver results by growing premium and service revenues profitably. The company operates in two segments: Managed Care and Specialty Services. Managed Care - This segment provides health plan coverage to individuals through Government subsidized programs, including Medicaid. Specialty Services - This segment consists of its specialty companies offering diversified healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups and other commercial organizations. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UnitedHealth Group (UNH) | United States | $291.300B | 15.31 |
| Cigna Group (CI) | United States | $68.961B | 9.09 |
| Humana (HUM) | United States | $28.676B | 12.60 |
| Molina Healthcare (MOH) | United States | $7.637B | 7.64 |
| Select Medical Holdings (SEM) | United States | $1.654B | 11.42 |
| Joint (JYNT) | United States | $0.116B | 0.00 |
| Aethlon Medical (AEMD) | United States | $0.001B | 0.00 |